Lilly is on track to file its oral GLP-1 agonist orforglipron for type 2 diabetes next year after presenting the first phase 3 data with the drug.

Listed are the Jefferson County property transfers for Jan. 13-19, 2025. They range in price from $20,000 to nearly $2.2M.